Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBADIAH-2 obeticholic acid trial in primary bile acid diarrhoea
2019-001531-32Phase 2Unknown
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of obeticholic acid in Bile acid diarrhea (BAD) (3 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Change in bowel function index at week 6. Status: unknown.
02
Drugs
obeticholic acid
03
Conditions
Bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2019-001531-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001531-32.